Skip to main content

#152156

Anti-Cytochrome P450 4A11 [M25-P2A10]

Cat. #152156

Anti-Cytochrome P450 4A11 [M25-P2A10]

Cat. #: 152156

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)

Class: Monoclonal

Application: ELISA ; IHC ; WB

Reactivity: Drosophila ; Human ; Mouse ; Rat ; Xenopus laevis

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Cytochrome P450 4A11 [M25-P2A10]
  • Research fields: Cancer;Cell signaling and signal transduction;Metabolism;Tissue-specific biology
  • Clone: M25-P2A10
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Drosophila ; Human ; Mouse ; Rat ; Xenopus laevis
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: CYP4A11 is upregulated in primary and metaststic CRC tumours compared to normal colon mucosa.
  • Immunogen: Peptide Sequence KNGIHLRLR (amino acids 499 507)
  • Isotype: IgG1 kappa
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: ELISA- Peptide immunogen; Western Blot- Human liver microsomes; IHC-Human liver

Target Details

  • Target: Cytochrome P450, family 4, subfamily A, polypeptide 11 (CYP4A11)
  • Tissue cell line specificity: ELISA- Peptide immunogen; Western Blot- Human liver microsomes; IHC-Human liver
  • Target background: CYP4A11 is upregulated in primary and metaststic CRC tumours compared to normal colon mucosa.

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Alnabulsi et al. 2017. Br J Cancer. :. PMID: 28557975.
  • The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
  • Alnabulsi et al. 2016. Characterisation of Arachidonic Acid Metabolising Enzymes in Colorectal Cancer J Pathol. 240 Suppl 1:S1-S48. PMID: 27747872
  • Nottingham Pathology 2016. 9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 28 June - 1 July 2016.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.